Clinical Trial Update: G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study [NA]

View source ↗

Summary

A post-market clinical study update shows that Zimmer Biomet's G7 Acetabular System with Vivacit-E or Longevity Liner PMCF study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis of the Hip
• Hip Fracture
• Osteoarthritis of the Hip
• Rheumatoid Arthritis of the Hip

Drugs mentioned

• G7 Acetabular System with Vivacit-E or Longevity Liner

Snippet

Sponsor: Zimmer Biomet | Conditions: Total Hip Arthroplasty, Degenerative Joint Disease of Hip | NA | Status: RECRUITING